Biotechnology

Filter

Current filters:

None

Popular Filters

63 to 87 of 2473 results

Vectura links with Janssen on asthma/COPD drug development

Vectura links with Janssen on asthma/COPD drug development

06-01-2015

UK inhaled therapies developer Vectura Group has entered into a global development and licence agreement…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingResearchRespiratory and PulmonaryVectura

CytomX expands leadership team with appointment of Michael Kavanaugh as chief scientific officer

CytomX expands leadership team with appointment of Michael Kavanaugh as chief scientific officer

05-01-2015

Oncology biotech company CytomX has appointed Michael Kavanaugh as chief scientific officer and head…

BiotechnologyBoardroomCytomXOncologyUSA

Amgen and Kite Pharma collaborate on CAR T cell therapies

05-01-2015

Kite Pharma has announced a strategic research collaboration and license agreement with US biotech giant…

AmgenBiotechnologyKite PharmaLicensingOncologyResearch

Boehringer Ingelheim and BioMed X to collaborate on COPD research

Boehringer Ingelheim and BioMed X to collaborate on COPD research

05-01-2015

German family-owned drug major Boehringer Ingelheim is to collaborate with the BioMed X Innovation Center.

BiotechnologyBoehringer IngelheimGermanyResearchRespiratory and Pulmonary

TxCell and Ferring collaborate with Trizell on lead product Ovasave

TxCell and Ferring collaborate with Trizell on lead product Ovasave

04-01-2015

French biotech firm TxCell on Friday announced a further enhancement to the development of its lead product…

BiotechnologyFerring PharmaceuticalsGastro-intestinalsLicensingOvaSaveResearchTrizell HoldingTxCell

NephroGenex reports positive results for QT study of Pyridorin

31-12-2014

US clinical stage firm NephroGenex says it has successfully completed a thorough QT/QTc (TQT) cardiac…

BiotechnologyDiabetesNephroGenexNephrology and HepatologyPyridorinResearch

Tikcro to fund cancer immune checkpoint antibodies research at Weizmann

31-12-2014

Israel’s Tikcro Technologies has entered into a research and license accord with Yeda Research and…

BiotechnologyIsraelLicensingOncologyResearchTikcro TechnologiesYeda Research and Development

US FDA approves wider use for Vertex’ Kalydeco

US FDA approves wider use for Vertex’ Kalydeco

30-12-2014

US biotech firm Vertex Pharmaceuticals says the US Food and Drug Administration has approved a supplemental…

BiotechnologyKalydecoRare diseasesRegulationUSAVertex Pharmaceuticals

BioMarin’s Vimizim approved in Japan for Morquio A syndrome

BioMarin’s Vimizim approved in Japan for Morquio A syndrome

29-12-2014

US biotech firm BioMarin Pharmaceutical has received approval from Japan’s Ministry of Health, Labor…

BioMarin PharmaceuticalBiotechnologyJapanRare diseasesRegulationVimizim

Janssen and Gilead expand agreement to develop HIV single-tablet regimen

Janssen and Gilead expand agreement to develop HIV single-tablet regimen

29-12-2014

US health care giant Johnson & Johnson’s Ireland-based subsidiary Janssen R&D Ireland has amended its…

Anti-viralsBiotechnologyCompleraEuropeGileadJanssenPrezistaResearchTybost

Roivant acquires GSK's Alzheimer's drug

Roivant acquires GSK's Alzheimer's drug

29-12-2014

Bermuda-based biotech firm Roivant Neurosciences, wholly-owned subsidiary of Roivant Sciences, has entered…

BiotechnologyGlaxoSmithKlineLicensingNeurologicalRoivant

First ever regulatory approval of Novartis' Cosentyx, in Japan

First ever regulatory approval of Novartis' Cosentyx, in Japan

26-12-2014

The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Swiss pharma giant Novartis’…

Anti-Arthritics/RheumaticsBiotechnologyCosentyxDermatologicalsJapanNovartisRegulation

Astellas and Cytokinetics expand accord on skeletal muscle activators

Astellas and Cytokinetics expand accord on skeletal muscle activators

26-12-2014

US biotech firm Cytokinetics and Japanese pharma major Astellas Pharma have amended their collaboration…

Astellas PharmaBiotechnologyCK-2127107CytokineticsLicensingResearch

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

24-12-2014

US specialty pharma firm Ariad Pharmaceuticals has entered into an agreement for Japan’s Otsuka Pharmaceuticals…

Ariad PharmaceuticalsAsia-PacificBiotechnologyIclusigJapanLicensingOncologyOtsuka PharmaceuticalResearch

US health care predictions from Steven Burrill

US health care predictions from Steven Burrill

24-12-2014

US politics will continue to be characterized by partisanship as the Republican majorities in the House…

BiosimilarsBiotechnologyHealthcarePoliticsRegulationUSA

Janssen partners with MacroGenics in up to $625 million deal

Janssen partners with MacroGenics in up to $625 million deal

23-12-2014

Shares of US biotech firm MacroGenics rocketed 11.7% to a 10-month high of $38.58 yesterday, on the news…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingMacroGenicsMergers & AcquisitionsMGD011Oncology

NICE opens consultation on Millennium’s Crohn’s drug Entyvio

23-12-2014

In draft guidance issued today, UK health costs watchdog the National Institute for Health and Care Excellence…

BiotechnologyEntyvioGastro-intestinalsMillennium PharmaceuticalsPricingRegulationTakeda PharmaceuticalUK

NewLink Genetic and Merck Ebola collaboration gets $30 million government award

23-12-2014

US biotech firm NewLink Genetics saw its shares gain 4.1% to $40.11 in morning trading on Monday, following…

Anti-viralsBiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesUSA

EpiVax links with Novozymes Biopharma to advance autoimmune diseases treatment

23-12-2014

Danish drugmaker Novozymes’ Veltis albumin-based half-life extension platform will help move Tregitope…

BiotechnologyImmunologicalsLicensingNovozymesResearchTregitopeVeltis

Stem cell sector offers investors high returns to rejuvenate their investment portfolios

Stem cell sector offers investors high returns to rejuvenate their investment portfolios

22-12-2014

Dr Husein K Salem, founder and chief executive of Precious Cells Group (PCG), one of the UK’s leading…

BiotechnologyFinancialMarkets & MarketingPrecious Cells GroupResearch

Sevion in antibody discovery accord with Johnson & Johnson Innovation and Janssen

22-12-2014

USA-based biopharma firm Sevion Therapeutics has entered into a collaboration agreement with CNA Development,…

BiotechnologyJanssenJohnson & JohnsonLicensingResearchSevion Therapeutics

Tiziana licenses anti-inflammatory foralumab from Novimmune

Tiziana licenses anti-inflammatory foralumab from Novimmune

22-12-2014

Oncology and immunology specialist Tiziana and antibody-based drug manufacturer Novimmune have entered…

BiotechnologyImmunologicalsLicensingNovImmuneTiziana

63 to 87 of 2473 results

Back to top